Explant Culture: An Advantageous Method for Isolation of Mesenchymal Stem Cells from Human Tissues
Overview
Authors
Affiliations
Mesenchymal stem cell (MSC) research progressively moves towards clinical phases. Accordingly, a wide range of different procedures were presented in the literature for MSC isolation from human tissues; however, there is not yet any close focus on the details to offer precise information for best method selection. Choosing a proper isolation method is a critical step in obtaining cells with optimal quality and yield in companion with clinical and economical considerations. In this concern, current review widely discusses advantages of omitting proteolysis step in isolation process and presence of tissue pieces in primary culture of MSCs, including removal of lytic stress on cells, reduction of in vivo to in vitro transition stress for migrated/isolated cells, reduction of price, processing time and labour, removal of viral contamination risk, and addition of supporting functions of extracellular matrix and released growth factors from tissue explant. In next sections, it provides an overall report of technical highlights and molecular events of explant culture method for isolation of MSCs from human tissues including adipose tissue, bone marrow, dental pulp, hair follicle, cornea, umbilical cord and placenta. Focusing on informative collection of molecular and methodological data about explant methods can make it easy for researchers to choose an optimal method for their experiments/clinical studies and also stimulate them to investigate and optimize more efficient procedures according to clinical and economical benefits.
Wei X, Xu A, Xia S, Wang J, Qiu Y, Wan G Arch Gynecol Obstet. 2024; 310(6):3239-3253.
PMID: 39623118 DOI: 10.1007/s00404-024-07854-y.
Navigating stem cell culture: insights, techniques, challenges, and prospects.
Gorska A, Trubalski M, Borowski B, Brachet A, Szymanczyk S, Markiewicz R Front Cell Dev Biol. 2024; 12:1435461.
PMID: 39588275 PMC: 11586186. DOI: 10.3389/fcell.2024.1435461.
Ningsih S, Jusman S, Syaidah R, Nauli R, Fadilah F Biol Methods Protoc. 2024; 9(1):bpae082.
PMID: 39554256 PMC: 11565194. DOI: 10.1093/biomethods/bpae082.
Mendiratta M, Mendiratta M, Ganguly S, Rai S, Gupta R, Kumar L Stem Cell Res Ther. 2024; 15(1):381.
PMID: 39468660 PMC: 11520827. DOI: 10.1186/s13287-024-03947-2.
Parishin A Inhibits Oral Squamous Cell Carcinoma via the AKT/mTOR Signaling Pathway.
Ma L, Liu Z, Kim E, Huang K, Kim C, Kim H Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458918 PMC: 11510427. DOI: 10.3390/ph17101277.